DEFINITIVE HEALTHCARE CORP

CF‑CFO Heller Casey’s steady sell‑offs signal a growing doubt in Definitive Healthcare’s upside, as the stock faces a steep 82% decline ahead of Q2 earnings.

Definitive Healthcare insiders buy 189k RSUs—signaling confidence in a low‑priced, high‑growth health‑analytics firm; could be a “buy the dip” cue for investors.

Insider Scott G’s June 4 RSU buy at 0.85 shows confidence in Definitive Healthcare’s future, despite a 75% YTD loss and steep stock dip.

Insider buying by Kathleen A. Winters signals confidence in Definitive Healthcare’s analytics platform amid a volatile market, hinting at potential upside despite current declines.

Insightful look at CFO Heller Casey’s insider sale of Definitive Healthcare shares—why it matters amid market volatility and a steep 75% YTD decline.

Insider selling at a low – what it means for Definitive Healthcare investors

Insider sales by Jason Krantz and CEO Kevin Coop reveal a strategic trim amid a 57% YTD drop, hinting at portfolio hedging rather than panic in Definitive Healthcare.

CEO Kevin Coop’s March 1 sale of 175k shares—tax‑driven, not bearish—shows Definitive Healthcare’s execs still hold long‑term stakes amid a 76% YTD plunge.

Insider sale of Definitive Healthcare shares sparks investor concern. Discover why Krantz’s February 2026 trade could signal short‑term doubts and what to watch for in upcoming filings.

Discover how CFO Heller Casey’s recent RSU purchase signals confidence in Definitive Healthcare’s upside, balancing insider sales and long‑term growth.